CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 1 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,954,882 | -14.5% | 685,061 | +24.6% | 4.21% | -31.1% |
| Q2 2023 | $17,484,500 | +88.7% | 550,000 | +44.7% | 6.11% | +99.6% |
| Q1 2023 | $9,268,200 | +36.7% | 380,000 | +76.7% | 3.06% | +15.0% |
| Q4 2022 | $6,781,100 | +176.7% | 215,000 | +207.1% | 2.66% | +578.3% |
| Q1 2022 | $2,451,000 | -66.4% | 70,000 | -68.9% | 0.39% | -85.2% |
| Q4 2021 | $7,295,000 | -4.9% | 225,000 | -13.5% | 2.65% | +36.8% |
| Q3 2021 | $7,669,000 | +49.7% | 259,966 | +30.0% | 1.94% | +5.6% |
| Q2 2021 | $5,124,000 | +38.2% | 200,000 | -25.9% | 1.83% | +45.7% |
| Q1 2021 | $3,707,000 | -17.2% | 270,000 | 0.0% | 1.26% | -46.9% |
| Q4 2020 | $4,477,000 | – | 270,000 | – | 2.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,713,470,000 | 41.39% |
| Perceptive Advisors | 6,511,727 | $184,021,000 | 5.34% |
| Finepoint Capital LP | 536,901 | $15,173,000 | 4.99% |
| Artal Group S.A. | 2,000,000 | $56,520,000 | 2.41% |
| Rock Springs Capital Management LP | 2,499,148 | $70,626,000 | 1.82% |
| Ikarian Capital, LLC | 178,100 | $5,033,000 | 1.00% |
| Hood River Capital Management LLC | 896,572 | $25,337,000 | 0.97% |
| Frazier Life Sciences Management, L.P. | 393,000 | $11,106,000 | 0.86% |
| HighVista Strategies LLC | 23,611 | $667,000 | 0.38% |
| FEDERATED HERMES, INC. | 3,313,333 | $93,635,000 | 0.27% |